Table 1. Baseline characteristics of ALPHA trial participants included in intent-to-treat analysis.
| Baseline Characteristic | Exercise (N = 122) | Control (N = 134) |
|---|---|---|
| Age (years), mean (SD) | 61.5 (5.4) | 60.7 (5.6) |
| Caucasian, n (%) | 109 (90.1)a | 125 (93.3) |
| Never smoker, n (%) | 88 (75.9)b | 82 (63.1)c |
| Body mass index (kg / m2), mean (SD) | 28.8 (4.2) | 29.6 (4.3) |
| Weight (kg), mean (SD) | 74.7 (12.3) | 77.4 (12.9) |
| Total activity (MET-hours/week), mean (SD) | 116.7 (60.7) | 134.4 (81.9) |
| Physical fitness (VO2max, ml/kg/min), mean (SD) | 26.8 (6.2) | 26.6 (6.1) |
| Alcohol (g/day), median (IQR) | 4.6 (6.0)d | 5.1 (7.9)a |
| Folate (mcg DFE/day), median (IQR)e | 405.7 (175.7)d | 425.6 (191.2)a |
a N miss = 1
b N miss = 6
c N miss = 4
d N miss = 3
e Dietary folate equivalents (DFE)